The efficacy and safety of topical rapamycin–calcitriol for facial angiofibromas in patients with tuberous sclerosis complex: a prospective, double‐blind, randomized clinical trial-Reference-Cited by-同舟云学术

The efficacy and safety of topical rapamycin–calcitriol for facial angiofibromas in patients with tuberous sclerosis complex: a prospective, double‐blind, randomized clinical trial

Published:2020-03-18 Issue:4 Volume:183 Page:655-663
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br. J. Dermatol.

Author:

Chen P.L.¹²,Hong J.B.³,Shen L.J.⁴,Chen Y.T.¹,Wang S.J.¹,Liao Y.H.³^ORCID

Affiliation:

1. Graduate Institute of Medical Genomics and Proteomics Taipei Taiwan

2. Department of Medical Genetics National Taiwan University Hospital Taipei Taiwan

3. Department of Dermatology National Taiwan University Hospital and National Taiwan University College of Medicine Taipei Taiwan

4. Graduate Institute of Clinical Pharmacy/School of Pharmacy College of Medicine National Taiwan University Taipei Taiwan

Funder

National Taiwan University Hospital

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.18949

Reference32 articles.

1. Tuberous sclerosis complex: Advances in diagnosis, genetics, and management

2. Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States

3. Shave Excision and Dermabrasion for Facial Angiofibroma in Tuberous Sclerosis

4. Treatment of angiofibromas with a scanning carbon dioxide laser: A clinicopathologic study with long-term follow-up

5. New technique using combined pulsed dye laser and fractional resurfacing for treating facial angiofibromas in tuberous sclerosis

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mTOR signaling is required for phagocyte free radical production, GLUT1 expression, and control of Staphylococcus aureus infection;mBio;2024-06-12

2. Effectiveness and safety of liposomal rapamycin for the treatment of facial angiofibromas in tuberous sclerosis;Farmacia Hospitalaria;2024-06

3. Efficacy and Safety of Topical Sirolimus for the Treatment of Angiofibromas in Tuberous Sclerosis: a Systematic Review and Meta-analysis;Current Pharmacology Reports;2023-12-13

4. A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin;Annales de Dermatologie et de Vénéréologie;2023-12

5. Optimization, Formulation, and Stability of Topical Rapamycin Used for Rare Tuberous Sclerosis Disease: from Ointment to Liposomes;Journal of Pharmaceutical Innovation;2023-12